U.S. lifts pause on Johnson & Johnson COVID-19 vaccine
CBSN
Federal health agencies say they are ending their recommended pause on use of Johnson & Johnson's Janssen vaccine, following the vote of a panel of advisers to the Centers for Disease Control and Prevention on resuming the single-shot vaccine.
The Food and Drug Administration says they have revised their emergency use authorization for the vaccine to include a new warning about the "plausible" risk of rare but serious blood clots in adult women under 50. A panel of advisers to the Centers for Disease Control and Prevention voted earlier Friday to recommend resuming use of the Johnson & Johnson vaccine. The shots are expected to be accompanied by a new warning about an increased risk of rare but serious blood clots for adult women under 50.More Related News
A coalition of conservation groups and Native American tribal citizens on Friday called on President Joe Biden to designate nearly 140,000 acres of rugged, scenic Badlands as North Dakota's first national monument, a proposal several tribal nations say would preserve the area's indigenous and cultural heritage.